For what it's worth CozzaD, I'm still intrigued.
It's like watching Lost and getting dripfed the plot!
Keep it up.
It's like watching Lost and getting dripfed the plot!
Keep it up.
Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature may not be available in some browsers.

Due to a number of factors, support for the current BigFooty mobile app has been discontinued. Your BigFooty login will no longer work on the Tapatalk or the BigFooty App - which is based on Tapatalk.
Apologies for any inconvenience. We will try to find a replacement.
You should have gone with Travis Cloke (and dagger) and used "smoke and shadows behind the windows".That was me. I'm glad others are familiar with it.
We have had to endure a certain poster going on (and on and on and on ...) about confirmation bias. And then suddenly, out of nowhere comes a poster with all these smoke and dagger* dealings. Classic case! Everyone hears what they want to hear.
And where does he choose to reveal this info that will shake the establishment to its core. Why, on BigFooty of course!
* I couldn't decide between smoke and mirrors or cloak and dagger, so I compromised.
The big kabosh! He's doing the chicken dance!"I couldn't be any happier," Schiavello said yesterday.
.
Log in to remove this Banner Ad
Comprehension of my post severely lacking it seems.
I don't care about your theories on linkage between supporters and religious beliefs.
I certainly do care about Essendon's long running campaign of BS and spin.
Hird is fighting the evidence, the process, anything he can to get off with a finding of innocence. It's the only option his ego and image of himself will brook.
Evans, Lukin and Demetriou (and Gill?), once it became clear that this couldn't be swept under the rug, came up with a plan that would wrap the whole thing up in a nice bow with a couple of not-so-innocent fall guys, Robinson and Dank. This plan would convince the public that it was all over, just a mistake, no intent to cross the line but we just stuffed up a little, terribly sorry, players were innocent, now let’s all get back to watching the footy with no need to dig any further.
Dank didn't like what he saw being put into motion and began leaking text messages and emails to warn those parties that he had dirt and wouldn't go quietly off into scapegoat purgatory. This set the connections onto a new plan with a somewhat varied scope due to: a) the public knew something more was up and was getting more and more angry; b) it prolonged the unresolved situation and gave certain investigators more time and incentive to dig; and c) James Hird had become irrevocably smeared.
It was at this time that Hird was called in and asked to fall on his sword gracefully to protect himself and all others involved. The intention was that he would “accept full responsibility” and “assure all Essendon fans that there was no intent to cheat”, but “in the interests of the club, the players and the game” he would “stand down until the matter was resolved”. This was intended to sate the public’s need for the big scalp, tie the whole thing up in a nice bow, it’s all over, just a mistake, no intent to cross the line but we just stuffed up a little, terribly sorry, players were innocent, now let’s all get back to watching the footy with no need to dig any further.
Hird refused to play this part, because in his mind he’s the hero, not the fall guy, and began going after Demetriou in public. Evans, knowing that Hird couldn’t be sacked at that juncture and not liking the way things were careening out of control, departed to enjoy his wealth in obscurity and hoping that the fallout wouldn’t find him.
Demetriou, realising that they’d lost control of the narrative and needing to give the public blood to settle things down, then leveraged the interim report into some stiff penalties for Essendon which included a 12 month ban for Hird where he’d be shipped out to France and hopefully the whole thing would be sorted out before he returned. However, ASADA were not to be assuaged by the governance sanctions and declined to cease their investigation once the AFL had de-camped from the partnership and Demetriou also decided to depart to enjoy his wealth in obscurity and hoping that the fallout wouldn’t find him.
Now here we are with Hird still fighting in a vain attempt to clear his name. Thing is, there’s way more to this than some footy players being doped and Hird has kept the public focussed on the issue for so long that a lot of digging has been done. The irony is, that had Hird listen to Evans mid-2013 and played the martyr, his image would very likely have come out this in much better shape. He could have been the poor, inexperienced and trusting coach and all-round good guy, who made the simple error of giving an either incompetent or dodgy operator in Dank too much leeway to administer his supplements program.
But now we’ve all seen the raging, grasping narcissist desperate to avoid responsibility at all cost and shift it to anybody else, no matter if friend or foe. More than that though, he will still likely go down for being a key component of instigating a team-wide doping program, and it’s also very likely that all the other dirt regarding the other shadowy backers of the program will also come out. All with James Hird front and centre and pleading his innocence amid a whirlwind of incontrovertible scandal.
Mirvac didn't get the rights to develop Waverley until 2001, well after Kennett shock defeat on the same day EFC lost the Prelim to Carlton (you should look and see if those two fact are related). Mirvac did manage to get the permit for the development in an amazingly quick 6 month under a labour government. Maybe you should look into that as well.It will probably revolve around Hawks/Waverley Park/Mirvac/Kennett dealings from 1999, but I haven’t gone down that path yet.
Fitzroy’s shaftage from 1996 needs to be revisited too, in my view.
OK?
Who was that?
"We got everything we wanted with James Hird coming in and Bomber Thompson coming back to our family, where he belongs. This will be a new era for the Bombers.
Other guests included Computershare founder Chris Morris, pharmacheutical company CSL's chief executive Brian McNamee and outgoing board member Beverly Knight, tipped to be replaced at next week's annual meeting by Paul Little, retiring chief of Australia's biggest transport company Toll Holdings.
Although I'm equally as intrigued by Hird getting what he deserves, I find the 'yeah, everyone knows the fat cats are crooks anyway, who cares?' mentality quite upsetting.
It's this precise mentality that is the reason for so much injustice and cruelty in the world.
And funnily enough, why a guy like Hird thought he'd get away with it.
So those baying for Hird's blood and not wanting to see him get away with it just because of who he is and who he knows, should also support those higher up copping the same whack.
Coz what evidence do you have that it works when injected?
Alright guys, play Investigator with me, there’s some Medical/Pharmaceutical info from 2009 onwards about AOD9064, if you guys want to help me then please review. I’ll sit this one out for a day or so.
Tim Boreham, Criterion From: The Australian
June 02, 2010 12:00AM
Calzada (CZD) 2.8c
AVEXA may have become a corporate corpse after ditching its HIV drug program last month, but as a cashed-up cadaver it is attracting interest from helpful parties suggesting other uses for its $23m residual kitty.
Having acquired a 12 per cent Avexa stake, Calzada's voice should be heard in the Avexa boardroom. But who's running the show? At an extraordinary meeting on July 6, holders will vote on a proposal by a mysterious gaggle of investors to remove chairman Nathan Drona and elect two of their own candidates.
"We think it is an interesting situation," says Calzada chairman David Franklyn. "The company has a reasonable amount of cash and it's looking for a future direction."
Here's one: more work on a revamped version of Calzada's fat-fighting compound AOD9604, which famously failed in orally delivered form in 2007, when Calzada was known as Metabolic.
Since then, a counterfeit injectable version has been sold to bodybuilders for up to $2500 a gram. Calzada has already allocated a small amount to salvage value from AOD9604, if only to investigate patent breaches.
Avexa's $23m would go a long way to funding an injectable trial -- and they only have to hang around gyms to find candidates.
Franklyn concurs the fat-fighting stuff has "potential", but so too does Calzada's Polynovo arm, which is developing biodegradable polymers for applications such as burns.
Meanwhile, Avexa holders are in the dark about the motives of the dissident holders, who haven't outlined how they will use the cash. We had Calzada as a spec buy at 3.5c on March 2 and maintain the call.
Avexa remains an avoid as the vultures fight over the scraps.
And this is the company who are selling AOD 9604, MONGRELS.
MelanotanPeptide.com
Best products and service under one planet.
We will win your loyalty.
Aromatase Inhibitors
Bulk Items
DHT Inhibitors
Hormones
Melanotan II
Melanotan II packages
Miscellaneous
Miscellaneous Supplements
PDE5 inhibitor
Peptides
SERMs
Solvents
Thermogenics
Wholesale Packages
JavaScript is disabled. In order to shop on this Web store, you must have JavaScript enabled.
For instructions on how to enable JavaScript, please see the help section of your browser. Once JavaScript is enabled please refresh the current page.Our Products >> (AOD 9604) 2mg
(AOD 9604) 2mg
Click To Enlarge
Item #: AOD 9604 2mg
The (AOD9604) is a stabilized analogue of the growth hormone-releasing factor (GRF) that induces growth hormone (GH) in a specific and physiological manner. Studies suggest that (HGH fragment 176-191) has several beneficial features: it reduces abdominal fat (in particular visceral fat), without compromising glycemic control (blood glucose), it increases muscle mass and improves the lipid profile. These characteristics make it an ideal candidate for the treatment of excess abdominal fat, an important aspect of HIV-associated lipodystrophy.
The HGH Fragment is a modified form of amino acids 176-191 at the C-terminal region of growth hormone.
► Reduces the most stubborn abdominal fat.
► Increases muscle mass.
► Increases IGF-1 levels, in an effective manner, thus making this a peptide that burns fat and exhibits anabolic function.
► Increases energy expenditure.
► Improves lipid profiles and lipolytic activity.
► Does not negatively impact blood glucose level, nor does cell proliferation occur, like Human Growth Hormone.
► Extremely potent and effective fat burner.
Storage:
REFRIGERATE OR FREEZE UPON RECEIPT.
Keep refrigerated after reconstitution.
All products contain sodium chloride for dilution.
Freeze-dried powder can be stored at -20 degree C for over a year.
Reconstituted solution should be kept in the refrigerator at 2-8 degree C and used as early as possible. If the reconstituted solution is cloudy, should be put into the refrigerator and kept for 24 hours.
Avoid multiple freeze-thaw cycles and exposure to frequent for lyophilized powder or reconstituted vials.
AND that figure of $2500 per gram is near enough to correct, they are selling it for $45 for 2 milligrams
http://www.proactiveinvestors.com.a...-for-obesity-and-osteoporosis-drug-16469.html
Calzada granted key U.S. patent for obesity and osteoporosis drug
Friday, May 20, 2011
Calzada granted key U.S. patent for obesity and osteoporosis drug
Calzada (ASX: CZD) has received formal notice of allowance from the US Patent and Trademark Office for the company’s “Methods For Preventing or Treating Bone Disorders” patent application.
Calzada subsidiary Metabolic’s major asset is the AOD9604 drug which has potential applications in the treatment of obesity and osteoporosis.
The U.S. patent adds to the company’s portfolio of osteoporosis patents already granted in Australia and China, as well as its core portfolio of obesity related patents granted in key international jurisdictions.
The U.S. application that expires in May 2025, claims priority from the Australian patent. The company has corresponding pending applications in Canada, Japan and before the European Patent Office.
David Kenley, chief executive officer of Calzada subsidiary Metabolic, said “grant of this key patent verifies that new potential applications of AOD9604 may also be capable of patent protection.”
Earlier this year, Calzada had success in an in vitro study on human osteoblasts using AOD9604.
Results showed the drug could be a good candidate for treating diseases such as osteoporosis or for applications promoting bone growth.
The global osteoporosis therapeutics market has been valued at $9.6 billion in 2009 by Innovaro (AMEX: INV).
Innovaro estimated then that the market would grow to $18.2 billion by 2017 due to an ageing world population.
Metabolic has investigated the potential of AOD9604 in both the obesity and bone health markets.
Investment in AOD9604 from 1998 to 2007 included around $50 million and the completion of six human clinical trials on 925 patients.
The company abandoned the research into AOD9604 in early 2007 when the completion of a large oral phase 2b human trial failed to prove efficacy of the drug.
However, a black market for the drug had been discovered with up to 30 Chinese websites offering the drug for sale, selling prices of up to US$30,000 per gram as well as being bought by distributors, gymnasiums, weight control centres, private clinics and individuals
Maybe AOD9604 is a fat killer after all.
From "The Age Insider":
Drug's fat chance
METABOLIC Pharmaceuticals' dreams crashed three years ago, when it terminated development of anti-obesity drug AOD9604 after spending around $60 million on development. At its peak, Metabolic (recently renamed Calzada) was capitalised at $500 million.
The company abandoned its weight-loss tablet after failing to establish efficacy in a large clinical trial. However, former Metabolic investors still lamenting lost fortunes may be interested by anecdotal evidence that they were let down not by the drug's lack of potential but by a management decision to focus exclusively on oral delivery in the belief that this was the only blockbuster market.
It seems increasing numbers of body builders are turning to blackmarket AOD9604, attracted by its fat-busting capabilities when injected directly into the abdomen. The Chinese-made knock-off almost certainly breaches Metabolic's patents but is doing brisk trade due to its reputation for moving stubborn belly fat.
Biochemists are unsurprised that bodybuilders are achieving results where Metabolic's clinical studies failed. When taken as a tablet the AOD9604 peptide, like all peptides, is prone to being broken down in the stomach and intestine before it can be absorbed into the bloodstream.
News of results achieved by bodybuilders comes after a recent announcement from Calzada that, after three years of inaction, it would once again be dedicating resources to generating value from the AOD9604 patents.
Calzada has around $11 million in the bank and trades at around cash backing. It may be a long-shot from here, but new management's challenge is to efficiently gather data on the efficacy of injectable AOD9604 before pursuing a licensing deal with a major pharmaceutical company.
I don't hold, but made a lot trading it (as MBP) years ago.
2009 AOD9064 announcement http://imagesignal.comsec.com.au/asxdata/20091123/pdf/01013897.pdf
Metabolic Today
Metabolic currently operates in the biotechnology space. Its portfolio of assets broadly consists of:
• The drug development portfolio including AOD9604, on which the company was initially established.
• The PolyNovo business in which Metabolic has invested $4.5 million for a 65.9% shareholding (approximately 1.5 cents
per Metabolic share, based on acquisition cost).
• Cash (in Metabolic) of approximately $10.25 million (approximately 3.4 cents per share).
Since the new Board was installed our focus has been to manage costs prudently; to establish a go-forward strategy for the AOD
compounds and to work with PolyNovo to ensure that it has the maximum opportunity to capitalize on the potential of its
• AOD9604 out-license strategy
The Board believes that the risk return profile of further significant investment in the development of AOD9604 or other drugs
cannot be justified as the path to market for any of the target applications is too long and risky.
Accordingly, the Board has adopted an out-licensing strategy for Metabolic’s legacy assets. AOD9604 which was initially
developed targeting obesity has also shown promising results in the treatment of osteoporosis in laboratory animal studies. Your
Board believes this outlicensing strategy provides the best prospect of achieving value from the company’s past investment in the
compound without allocating significant further capital.
On the 13 August 2009 Metabolic entered into a collaboration with ASX listed Phosphagenics Ltd to develop a transdermal
application of AOD9604 which, if successful, provides the Company with a long term royalty stream but with very limited capital
requirements.
The Board is investigating other outlicensing opportunities for AOD9604, one of these is attracting solid interest, although
discussions remain at an early stage.
Metabolic Address
Unit 2, Level 1, 320 Lorimer St,
Port Melbourne, Victoria
ABN 96 083 866 862
http://imagesignal.comsec.com.au/asxdata/20090813/pdf/00977069.pdf
http://www.sharescene.com/index.php?showtopic=54&st=0
if that's all you have, your research hasn't been very thorough.
i was holding out hope you might have something interesting and informative to share. you lost me completely though after your post claiming a betting conspiracy (worthy of a royal commission apparently) involving the ALP because matty primus and a labor man who happens to be a bulldogs board member made small bets on geelong games while *gasp* bomber thompson was coach.
there's far more recent and comprehensive information on the efficacy and anabolic effects of AOD-9604 - including all the results of dank's trials on 'professional footballers' - in publicly available documents on the web.
but since you aren't exactly forthcoming with all of your supposed intel, i think i'll do likewise and leave you to find it yourself. or maybe i'll drip-feed some oblique hints over the next few days![]()
if that's all you have, your research hasn't been very thorough.
i was holding out hope you might have something interesting and informative to share. you lost me completely though after your post claiming a betting conspiracy (worthy of a royal commission apparently) involving the ALP because matty primus and a labor man who happens to be a bulldogs board member made small bets on geelong games while *gasp* bomber thompson was coach.
there's far more recent and comprehensive information on the efficacy and anabolic effects of AOD-9604 - including all the results of dank's trials on 'professional footballers' - in publicly available documents on the web.
but since you aren't exactly forthcoming with all of your supposed intel, i think i'll do likewise and leave you to find it yourself. or maybe i'll drip-feed some oblique hints over the next few days![]()
I think we all understand that CozzaD has some interesting posts that are getting the bullsh!t antennae of more than a few posters to wiggle like a South American pop singer.
I didn't know all the stuff he posted, and have been happy to fill in some gaps in my background knowledge - but as NikkiNoo has pointed out to me elsewhere, the reason for this guy being on BF and posting this stuff really only has one possible motivation ... and I don't think he will be able to skirt around it much longer.
There has been plenty views on this thread. The only thing that comes to mind is Chief boosting advertising over the off season??I think we all understand that CozzaD has some interesting posts that are getting the bullsh!t antennae of more than a few posters to wiggle like a South American pop singer.
I didn't know all the stuff he posted, and have been happy to fill in some gaps in my background knowledge - but as NikkiNoo has pointed out to me elsewhere, the reason for this guy being on BF and posting this stuff really only has one possible motivation ... and I don't think he will be able to skirt around it much longer.
Im still not sure that cozzad has actually made one single point.
So far he has just referenced lots of partially linked things and turned it into a mass ALP conspiracy (right on election eve).
Sounds suss at this stage.
So far cozzad is insinuating:
1. Evans and Kelty are the ring-leaders of the pharmaceutical experiment (financial incentives)
2. When they got wind of the ACC investigation they executed a high level cover-up (they had close connections to Gillard)
3. It was decided by those higher up that if a scapegoat was needed it would be Lord James Albert.
If that is indeed what you are selling cozzad - noone buys it.
I really hope you have something better than this.
Thanks for the reminder!Title: Evans ran the program
I think you nailed itSince all these explosive revelations are coming to light, here's a copy of the consent forms!
http://i.imgur.com/CwK7cQn.png
Since all these explosive revelations are coming to light, here's a copy of the consent forms!
http://i.imgur.com/CwK7cQn.png
did laugh
doesn't even need transcribing for Herald-Sun readers.
send it poste haste to Robbo....or Titus.....whoever is their chief footy writer these days.